S Honda, H Hirabayashi, Y Tsukahara, A Negi - Graefe's Archive for Clinical and Experimental …, 2008 - Springer Abstract Background Despite the recent reports describing the benefits of the
intravitreal injection of bevacizumab (IVB) to treat ocular neovascular
disorders, including retinopathy of prematurity (ROP), the possible adverse ... Cited by 13 - Related articles - BL Direct - All 4 versions
S Moradian, H Ahmadieh, M Malihi, M … - Graefe's Archive for Clinical and Experimental …, 2008 - Springer Abstract Background Vitreous concentration of vascular endothelial growth factor
(VEGF) rises significantly during prolifera- tive diabetic retinopathy (PDR).
Bevacizumab (Avastin) is a humanized monoclonal antibody to VEGF. ... Cited by 11 - Related articles - All 2 versions
S Kusaka, C Shima, K Wada, H Arahori, H … - British Medical Journal, 2008 - bjo.bmj.com Methods: A retrospective chart review was conducted of 23 consecutive eyes
(stage 3, three eyes; 4A, 18 eyes; 4B, two eyes) of 14 patients with vascularly
active ROP considered at high risk for progression or development of ... Cited by 10 - Related articles - All 5 versions
K Sayanagi, Y Ikuno, K Soga, T Wakabayashi … - Acta Ophthalmol (Copenh), 2008 - interscience.wiley.com Cases report: Three eyes of three patients with mCNV were examined with
fluorescein angiography (FA) and ICGA using Heidelberg Retinal Angiograph 2 and
the conventional fundus camera before and after IVB. The cessation of ... Cited by 3 - Related articles - All 3 versions
PV Algvere, A Kvanta, S Seregard - Acta ophthalmologica, 2008 - ncbi.nlm.nih.gov 1: Acta Ophthalmol. 2008 Jun;86(4):352-5. Shall we use Avastin or Lucentis for
ocular neovascularization? Algvere PV, Kvanta A, Seregard S. ... Cited by 3 - Related articles - BL Direct - All 2 versions
JB Gunther, MM Altaweel - Survey of Ophthalmology, 2009 - Elsevier The use of intravitreal bevacizumab (Avastin) has greatly expanded since its
introduction into ophthalmic care 3 years ago. A PubMed search on 1 August 2008
revealed 51 ocular disease processes that have been treated with ... Cited by 2 - Related articles - All 23 versions
JB Jonas, M Schmidbauer, F Rensch - Acta ophthalmologica, 2008 - ncbi.nlm.nih.gov 1: Acta Ophthalmol. 2008 Jun 20. [Epub ahead of print]. Progression of tractional
retinal detachment following intravitreal bevacizumab. ... Cited by 1 - Related articles - All 2 versions
MS Figueroa, I Contreras, S Noval - Current diabetes reviews, 2009 - ncbi.nlm.nih.gov Anti-VEGF drugs may be employed in the surgical treatment of diabetic
retinopathy: 1. Prior to surgery. The intravitreal injection of anti-VEGF drugs
leads to a significant reduction of neovascularization, with a reduction in ... Cited by 1 - Related articles - All 2 versions
R Krishnan, S Goverdhan, J Lochhead - Eye, 2008 - nature.com Jump to main content; Jump to navigation; nature.com homepage; Publications AZ index;
Browse by subject. My account; Submit manuscript; Register; Subscribe; RCOphth ... Cited by 1 - Related articles - All 3 versions
WR LO, SJ KIM, TM AABERG Sr, C … - Retina, 2009 - journals.lww.com From the *Department of Ophthalmology, Emory University, Atlanta, Georgia; and
†Department of Ophthalmology, Vanderbilt University, Nashville, Tennessee.
Supported in part by an unrestricted grant from Research to Prevent ... Cited by 1 - Related articles - All 2 versions
